Skip to contentSkip to footer
      employer cover photo
      employer logo
      employer logo

      NanoString

      Is this your company?

      Find the right fit for you - faster

      Get tailored insights about working at NanoString in one quick step.

      NanoString Snapshot

      3.6
      based on 199 ratings

      59% would recommend to a friend

      Brad Gray

      54% approve of CEO

      1 OfficeLocations
      Description NanoString Technologies provides life science tools for translational research and molecular diagnostic products. The nCounter Analysis System offers a cost-effective way to easily profile the expression of hundreds of genes, proteins, miRNAs, or copy number variations, simultaneously with high sensitivity and precision, facilitating a wide variety of basic research and translational medicine applications, including biomarker discovery and validation. The company's technology is also being used in diagnostics. The Prosigna Breast Cancer Prognostic Gene Signature Assay together with the nCounter Dx Analysis System is FDA 510(k) cleared for use as a prognostic indicator for distant recurrence of breast cancer. In addition, the company is collaborating with multiple biopharmaceutical companies in the development of companion diagnostic tests for various cancer therapies.

      http://mendelspod.com/podcasts/bringing-home-some-diagnostics-gold-brad-gray-nanostring-show-how-its-done/

      Life at NanoString

      Related searches: NanoString jobs | NanoString salaries | NanoString benefits | NanoString interviews
      CompaniesAbout NanoString

      Glassdoor gives you an inside look at what it's like to work at NanoString, including salaries, reviews, office photos, and more. This is the NanoString company profile. All content is posted anonymously by employees working at NanoString.